Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

value

- PMLiVE

AIDS pandemic now at ‘the beginning of the end’

ONE Campaign says drug access is making the difference, but there's still more to do

- PMLiVE

First trial results positive for GSK Ebola vaccine

ChAd3-EBO is safe and able to stimulate response

- PMLiVE

UK e-cigarette advert comes under fire

BMA accuses campaign of glamorising smoking

The balance of power in healthcare

Meeting patient needs and keeping pace with technological advances

- PMLiVE

Market access and the importance of early stakeholder engagement

Join the webinar on December 10

- PMLiVE

Using humour in healthcare marketing

Is laughter the best medicine?

- PMLiVE

Power to the people: an era of self-care

Pharma should consider what a patient-centric approach to care really means

- PMLiVE

Novo Nordisk’s Klaus Henning Jensen on trends in medical affairs

PMLiVE speaks to the head of clinical, medical and regulatory for Novo in the UK and Ireland

EU flag

EU consortium focuses on antibiotic ‘husbandry’

IMI-backed group to research ways to tackle antimicrobial resistance

- PMLiVE

EU boost for GSK’s Ebola vaccine research

And EMA says it' poised to assess possible vaccines or treatments

EU flag

EC: medicines to remain part of health directorate

Juncker U-turns on decision to move pharma oversight to enterprise and industry

- PMLiVE

J&J to produce one million doses of Ebola vaccine

Commits $200m to speed up research

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links